CN Stock MarketDetailed Quotes

688520 Sinocelltech Inc.

Watchlist
  • 38.35
  • +0.15+0.39%
Noon Break Dec 5 11:29 CST
17.08BMarket Cap-650000P/E (TTM)

About Sinocelltech Inc. Company

The company is an innovative biopharmaceutical and vaccine research and development company founded by Dr. Xie Liangzhi, an internationally renowned biopharmaceutical R&D and industrialization expert and expert in the New Drug Creation Project Group. It is committed to developing products with differentiated competitive advantages, providing high-quality and low-cost options for domestic and foreign patients, and establishing a leading biopharmaceutical brand. The company has long been committed to developing biopharmaceuticals with differentiated competitive advantages, focusing on the development and industrialization of biopharmaceutical products in various fields of treatment and prevention, such as malignant tumors, autoimmune diseases, infectious diseases, and genetic diseases. The company's main products are SCT800, SCT400, SCT630, SCT510, SCTV01, SCT-I10A, SCT1000, SCT650C, SCTC21C, etc. SCTB35 SCTB14

Company Profile

Short Name-A神州细胞集团公司
Company NameSinocelltech Group Limited
Listing DateJun 22, 2020
Issue Price25.64
Shares Offered50.00M share(s)
FoundedApr 23, 2007
Chairmanliangzhi xie
Legal Representativeliangzhi xie
General Managerliangzhi xie
Secretaryliming tang
Employees2333
ProvinceBei Jing Shi
Phone010-58628328
Office AddressBuilding 5, No. 31, Kechuang 7th Street, Beijing Economic and Technological Development Zone, Beijing
Zip Code100176
Registered Address307, Building 5, No. 31, Kechuang 7th Street, Beijing Economic and Technological Development Zone, Beijing
Fax010-58628299
Emailir@sinocelltech.com
Business License9111030266050567XF
BusinessResearch and development of biomedical products and vaccines; property management. (Enterprises independently select business projects and carry out business activities in accordance with law; projects subject to approval according to law carry out business activities according to the approved content after approval by the relevant departments; they are not allowed to engage in business activities for projects prohibited or restricted by the city's industrial policy.)

Company Executives

  • Name
  • Position
  • Salary
  • liangzhi xie
  • Chairman, Directors, General Manager, Core Technical Personnel
  • 171.10K
  • yang wang
  • Directors, Deputy General Manager, Core Technical Personnel
  • 3.38M
  • liming tang
  • Directors, Board Secretary, Deputy General Manager
  • 2.40M
  • weiqiang han
  • Directors
  • --
  • wei he
  • Independent Directors
  • 180.00K
  • xiaochuan wang
  • Independent Directors
  • 180.00K
  • zhiguo su
  • Independent Directors
  • 180.00K
  • yan ceng
  • Securities Affairs Representative
  • --
  • xun li
  • Chairman of the Supervisory Board, Employee Supervisors
  • 825.90K
  • jilei jia
  • Auditors
  • 673.70K
  • shuhuan zhao
  • Auditors
  • --
  • zhanghua lan
  • Deputy General Manager
  • 2.11M
  • jie ma
  • Chief Financial Officer
  • 944.70K
  • chunyun sun
  • Core Technical Personnel
  • 1.38M
  • yanjing zhang
  • Core Technical Personnel
  • 1.26M
  • fanbin pan
  • Core Technical Personnel
  • 831.00K
  • wenlin gai
  • Core Technical Personnel
  • 2.57M
  • chunxia luo
  • Core Technical Personnel
  • 1.47M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data